Abstract 318: Demystifying tumor heterogeneity with a fully automated, high-throughput single-cell DNA-Seq (scDNA-seq) workflow
Xuan Li,Raymond Mendoza,Samantha Leong,Hima Anbunathan,Mike Covington,Mohammad Fallahi,Bryan Bell,Shuwen Chen,Yue Yun,Andrew Farmer
DOI: https://doi.org/10.1158/1538-7445.am2024-318
IF: 11.2
2024-04-04
Cancer Research
Abstract:Objective: Genetic heterogeneity is a key factor underlying tumor drug resistance and metastatic potential. Understanding this heterogeneity is therefore vital to improving both prognosis and treatment. Next-generation sequencing is a valuable tool for analyzing the genetic makeup of tumors. However, bulk sequencing methods lack the sensitivity to fully resolve tumor heterogeneity. While single cell methods provide a powerful approach to dissect such heterogeneity, to date, these methods have been limited in their throughput. To address this bottleneck, we have developed a fully automated workflow for generating scDNA-seq libraries based on PicoPLEX® whole genome amplification (WGA) technology. This high-throughput method, which has been optimized on our ICELL8® cx Single-Cell System, enables the generation of WGA libraries for >1,000 single cells within one day. Methods: We first sought to demonstrate the ability of this new high-throughput method to generate WGA libraries of comparable quality to the standard PicoPLEX workflow in terms of genome coverage, GC bias, and other typical quality metrics. We additionally assessed copy number variant (CNV) detection sensitivity using two cell lines with well-characterized small segmental CNVs: GM22601 (~25Mb deletion on chromosome 4) and GM05067 (~45Mb gain on chromosome 9). We also analyzed a lymphoblastoid line (K562) that carries a range of chromosomal aneuploidies. A total of 1,288 single-cell WGA libraries were generated and sequenced to a depth of 250K paired-end reads per cell. Data analysis was done using the Ginkgo CNV pipeline with an average bin size of 500 kb. As a final proof of principal, we also generated single cell data using tumor and adjacent normal tissue from two clear cell renal cell carcinoma (ccRCC) samples. Results: Libraries generated using our high-throughput workflow had a high mapping rate, with 94.1% of the reads being uniquely mapped. Additionally, the libraries were comparable to those generated with the standard PicoPLEX workflow in terms of coverage uniformity, GC bias and other metrics. Moreover, the segmental aneuploidies in both GM22601 and GM05067 were reliably detected in >90% of cells at a read depth as low as 250,000 reads per cell. Analysis of the ccRCC samples revealed subclonal heterogeneity with various CNVs common to ccRCC, including deletion of chr. 3p, amplification of chr. 5q, and duplication of chr. 2. Conclusion: By adapting PicoPLEX technology to high throughput using the ICELL8 cx Single-Cell System, we have obtained single-cell WGA libraries from up to 1,200 cells at once and enabled the reliable detection of CNVs and tumor subclones at a shallow sequencing depth. In addition, by leveraging the automated nanoliter-dispensing capabilities of ICELL8 cx system this method provides a significant reduction in reagent use and labor compared to plate-based methods. Citation Format: Xuan Li, Raymond Mendoza, Samantha Leong, Hima Anbunathan, Mike Covington, Mohammad Fallahi, Bryan Bell, Shuwen Chen, Yue Yun, Andrew Farmer. Demystifying tumor heterogeneity with a fully automated, high-throughput single-cell DNA-Seq (scDNA-seq) workflow [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 318.
oncology